Relevance of tumor boards for the inclusion of patients in oncological clinical trials

Abstract Introduction Major national and international oncological societies generally recommend treating a significant proportion of oncological patients in clinical trials to improve therapy strategies for cancer patients. At cancer centers, the recommendation about the appropriate therapy for the...

Full description

Bibliographic Details
Published in:	Journal of Cancer Research and Clinical Oncology
Main Authors:	Hendrik Dapper, Maurice Dantes, Peter Herschbach, Hana Algül, Volker Heinemann
Format:	Article
Language:	English
Published:	Springer 2023-03-01
Subjects:	Tumor boards Oncological clinical trials Patient recruitment
Online Access:	https://doi.org/10.1007/s00432-022-04559-0

Similar Items

Correction: Relevance of tumor boards for the inclusion of patients in oncological clinical trials
by: Hendrik Dapper, et al.
Published: (2025-01-01)

Screening log: Challenges in community patient recruitment for gynecologic oncology clinical trials
by: Rubina Ratnaparkhi, et al.
Published: (2024-12-01)

Leveraging the EHR4CR platform to support patient inclusion in academic studies: challenges and lessons learned
by: Yannick Girardeau, et al.
Published: (2017-02-01)

Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
by: Eliya Farah, et al.
Published: (2023-09-01)

Regionalization of Head and Neck Oncology Tumor Boards: Perspectives of Collaborating Physicians
by: Neha B. Amin, et al.
Published: (2023-01-01)

Effectiveness of IT-supported patient recruitment: study protocol for an interrupted time series study at ten German university hospitals
by: Martin Boeker, et al.
Published: (2024-02-01)

The role of molecular tumor boards in neuro-oncology: a nationwide survey
by: Lisa S. Hönikl, et al.
Published: (2024-01-01)

Changes in patient recruitment parameters and their derivatives under the influence of external factors – population size and density of residence in a certain area
by: S. S. Milovanov
Published: (2024-05-01)

Parameters and indicators selection of clinical centers in predicting the patients enrollment for clinical trials
by: Svyatoslav S. Milovanov
Published: (2023-12-01)

Evaluation of 2024 Turkish Medical Oncology Board Exam with ChatGPT
by: Emir Gökhan KAHRAMAN, et al.
Published: (2025-04-01)

Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards
by: Cosima Strantz, et al.
Published: (2025-01-01)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
by: Yeonju Kim, et al.
Published: (2023-08-01)

Patients’ and researchers’ experiences with a patient board for a clinical trial on urinary tract infections
by: Imke Schilling, et al.
Published: (2019-11-01)

A comparative study of Watson for Oncology and tumor boards in breast cancer treatment
by: Dohoon Kim, et al.
Published: (2019-06-01)

Putting Patients First: Pragmatic Trials in Gynecologic Oncology
by: Laura Hopkins, et al.
Published: (2025-02-01)

Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
by: Lauren A. Marcath, et al.
Published: (2018-11-01)

Challenges in Diversity, Equity, and Inclusion in Research and Clinical Oncology
by: Wafik S. El-Deiry, et al.
Published: (2021-03-01)

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases
by: Mark C. Korpics, et al.
Published: (2023-05-01)

Editorial: Rising stars in radiation oncology 2022
by: TJ FitzGerald, et al.
Published: (2023-06-01)

Benchmarking LLM chatbots’ oncological knowledge with the Turkish Society of Medical Oncology’s annual board examination questions
by: Efe Cem Erdat, et al.
Published: (2025-02-01)

Evaluating Treatment Plan Modifications from Surgeons’ Initial Recommendations to Multidisciplinary Tumor Board Consensus for Cancer Care in a Resource-Limited Setting
by: Sajida Qureshi, et al.
Published: (2025-05-01)

Signalomics for molecular tumor boards and precision oncology of breast and gynecological cancers
by: Tatiana V Denisenko, et al.
Published: (2025-06-01)

Patterns of Patient Recruitment in Clinical Studies on the Example of International Multicenter Clinical Studies (IMCTs)
by: S. S. Milovanov
Published: (2023-09-01)

Implementing oncology clinical trials in Nigeria: a model for capacity building
by: Atara Ntekim, et al.
Published: (2020-08-01)

Implementation of investigator-led drug clinical trial recruitment
by: SONG Xia, KAN Tingting, ZHU Ling, CHEN Peiling, ZHANG Haitao
Published: (2024-12-01)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
by: Veronica Agostinelli, et al.
Published: (2023-10-01)

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer
by: He Huang, et al.
Published: (2022-08-01)

The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy
by: Veronica Agostinelli, et al.
Published: (2025-02-01)

Physician recruitment of patients to non-therapeutic oncology clinical trials: ethics revisited
by: Lee eBlack, et al.
Published: (2013-03-01)

Pioneering the implementation of a precision oncology strategy in Portugal: the Precision Oncology Platform trial
by: Beatrice Mainoli, et al.
Published: (2024-06-01)

Factors affecting patient participation in clinical trials in Ireland: A narrative review
by: Elaine Walsh, et al.
Published: (2016-08-01)

Advancing Academic Cancer Clinical Trials Recruitment in Canada
by: Rebecca Y. Xu, et al.
Published: (2021-07-01)

Perspective: rethinking therapeutic strategies in oncology
by: Edward F. Patz, et al.
Published: (2024-01-01)

Clinical research nurse predictions of trial failure, recruitment and retention: a case for their early inclusion in trial design
by: Frances Shiely, et al.
Published: (2023-07-01)

Usage and perceived effectiveness of recruitment techniques among clinical trials recruiters
by: Jewels Watts, et al.
Published: (2025-01-01)

Sponsorship of oncology clinical trials in the United States according to age of eligibility
by: Dylan V. Neel, et al.
Published: (2020-07-01)

Increasing patient participation in oncology clinical trials
by: Jie Chen, et al.
Published: (2023-02-01)

Extending experimentation: oncology’s fading boundary between research and care
by: Alberto Cambrosio, et al.
Published: (2018-07-01)

Effects of blended learning training for oncology physicians to advise their patients about complementary and integrative therapies: results from the multicenter cluster-randomized KOKON-KTO trial
by: Stefanie M. Helmer, et al.
Published: (2023-09-01)

Primary physicians’ attitudes toward their patients receiving a proposal to participate in a vaccine trial
by: Maelle Detoc, et al.
Published: (2019-12-01)